Keynote & Panels

Medtech 2020: Venture Capital Outlook

February 18th, 2020
7:40 - 8:25pm

In this panel we'll talk to active VCs about the types of deals they are in now and we'll find out what new deals they are looking for in 2020.  

Insights and Opinions From Big Company Executives Turned Entrepreneurs

February 19th, 2020
1:05 - 1:45pm

In this panel we’ll hear the experiences and insights from ex- big company executives who’ve chosen the entrepreneurial path and are now leading early stage medtech ventures.  We’ll have them share war stories, perspectives of being on both sides of the table, and find out what they are up to next -- and why.  The executives on this panel have held senior positions with the some of the largest medtech strategics and have multiple exits under their belts as entrepreneurs. 

Join us for an informative (and fun) discussion with panelists Jim Corbett (Boston Scientific, ev3, MicroTherapeutics, Alphatec Spine), Todd Usen (Olympus, Smith & Nephew, Boston Scientific), Brian Verrier (Covidien, Medtronic), Paul Molloy (Telefex, VasoNova, Micardia), and Tim Moran (ConvaTec, Covidien).

The panel will be moderated by industry insider and Alira Health Senior Partner & VP, David Uffer.

Future Trends in Medtech Innovation: 2020 Vision

February 20th, 2020
8:00 - 8:40am

The Strategic Outlook on Medtech Deal-Making

February 19th, 2020
11:30am - 12:10pm

In this panel we'll get insights from leading medtech strategics J&J, Medtronic, Terumo, and Intuitive Surgical.  We will discuss the types of deals they are looking for and have each stakeholder weigh in on deal structure trends and provide a perspective on where they see M&A in 2020 and beyond.    

We will also learn about an important global strategic partnership formed in 2019 between Terumo & Orchestra BioMed and how this innovative approach to risk/reward sharing for product development and commercialization might shape future deal-making opportunities for strategics and innovators.

2020: Hot Topics in Clinical Affairs

February 20th, 2020
Noon - 1pm

Saving money, speeding enrollment and generating real world evidence in clinical studies.  Hear from industry experts, Ori Ben-Yehuda, MD, Tonya Dowd & Lisa Beck, about how to efficiently manage a clinical trial and generate real world evidence to support reimbursement and regulatory decisions.

This panel discussion will be hosted by MCRA and will run during a lunch session.  Space is limited. To reserve your spot, please RSVP here.

Early Reimbursement & Market Access Planning: Not Optional

February 18th, 2020
Noon - 1:00pm

In this panel we'll get a "from the trenches" perspective on reimbursement and market access strategies directly from the key stakeholders; the CEO, Strategic Investor, Venture Capitalist, and Payer.  This group will share their insights and experiences (some positive, some painful) on why having a proper reimbursement and market access strategy is so critical. 

The panel will be moderated by medtech industry veteran and reimbursement thought leader, Tonya Dowd.  Tonya is MCRA's Vice President of Reimbursement, Health Economics and Market Access.

Non-Traditional VC, Family Office, Angel & CrowdSourcing in 2020

February 20th, 2020
1:05 - 1:45pm

In this panel we’ll hear from active medtech angels, family office, and other non-traditional early stage investors.  What are they investing in?  What are they bringing to the table besides capital?  What kind of deals are they interested in right now? 

This group of panelists represent a new CrowdSourcing & Direct Investment Platform, 4 Lifescience Angel Groups, 2 Family Offices, and a new VC fund focused exclusively on early-stage deals.

Health Economics and Outcomes Research (HEOR): From Concept to Implementation

February 20th, 2020
11:20am - 12:00pm

This panel will introduce the audience to Health Economics and Outcomes Research (HEOR) fundamentals, how HEOR strategies can be implemented at the different stages of product development, and how to use HEOR to drive value at each stage of the development lifecycle.